Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

Enlivex Therapeutics, Ltd.

Table 1: Newly Registered and Carry Forward Securities

Line Item Type		Security Type		Security Class Title		Notes		Fee Calculation Rule		Amount Registered		Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price			Fee Rate		Amount of Registration Fee
Newly Registered Securities
Fees to be Paid		Equity		Ordinary Shares, $0.40 par value per share (Ordinary Shares)		(1)		Other		212,000,000		$	0.83		$	175,960,000.00		0.0001381		$	24,300.08
Total Offering Amounts:															$	175,960,000.00					24,300.08
Total Fees Previously Paid:																					0.00
Total Fee Offsets:																					0.00
Net Fee Due:																				$	24,300.08

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also covers such additional shares as may hereafter be offered or issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations or certain other capital adjustments.

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The price per share and aggregate offering price are based on the average of the high and low prices of the Ordinary Shares on December 19, 2025 as reported on the Nasdaq Capital Market.

Consists of (i) 210,108,768 Ordinary Shares acquired by the Selling Shareholders in the Private Placement and (ii) 1,891,232 Ordinary Shares issuable upon the exercise of pre-funded warrants acquired by certain of the Selling Shareholders in the Private Placement.